Compare AAMI & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | AAMI | HTFL |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | AAMI | HTFL |
|---|---|---|
| Price | $55.26 | $24.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $54.33 | $38.20 |
| AVG Volume (30 Days) | 226.9K | ★ 1.5M |
| Earning Date | 04-30-2026 | 05-10-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.60 | $23.36 |
| Revenue Next Year | $12.41 | $23.03 |
| P/E Ratio | $23.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.60 | $20.13 |
| 52 Week High | $58.36 | $41.22 |
| Indicator | AAMI | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 58.77 | 49.41 |
| Support Level | $46.04 | $20.27 |
| Resistance Level | $56.16 | $25.05 |
| Average True Range (ATR) | 1.94 | 1.92 |
| MACD | 0.46 | 0.09 |
| Stochastic Oscillator | 66.78 | 49.53 |
Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.